Skip Navigation Buttons    Contact   
Logo: BRS BRS/BORS First Joint MeetingLogo: BORS
Call for
Guidelines for
Dates to remember
Page body.

Exhibition and Sponsorship

This will be the first joint meeting of the newly named Bone Research Society (former Bone and Tooth Society) and the British Orthopaedic Research Society.  We are expecting at least 300 delegates to attend the meeting and they will include endocrinologists, rheumatologists, orthopaedic surgeons, geriatricians and others interested in all aspects of bone and its diseases.

Exhibition and sponsorship opportunities are available. For information please contact Janet Crompton.

Information for exhibitors


The Bone Research Society and British Orthopaedic Research Society gratefully acknowledge the support of the following:
(list as at April 2006):

Major Sponsors
Eli Lilly
Merck Sharp and Dohme
Servier Laboratories
Shire Pharmaceuticals
The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals and Sanofi Aventis)
Other Supporters
Biomet UK Ltd
Immunodiagnostic Systems (IDS)
Olympus Keymed
Oxford Biosystems
Regenerative Medicine

Eli Lilly and Company

    Eli Lilly and Company

Eli Lilly and Company is one of the world's largest research-based pharmaceutical companies, dedicated to creating and delivering innovative pharmaceutical healthcare solutions that enable people to live longer, healthier and more active lives. Our research and development efforts constantly strive to address the world’s growing unmet medical needs in several therapeutic areas.

To assist in the therapeutic management of Osteoporosis, Lilly has two products, each catering for different patient needs.

For information about either of our osteoporosis products or services, please come and talk to us at the Lilly stand. We look forward to meeting you.

Merck Sharp & Dohme Limited

    Merck Sharp & Dohme Limited

Merck Sharp & Dohme Limited (MSD) is the UK subsidiary of Merck & Co., Inc. of Whitehouse Station, New Jersey, USA, a leading research-based pharmaceutical company that discovers, develops, manufactures and markets a wide range of innovative pharmaceutical products to improve human health.



Pfizer, with its UK business headquarters in Surrey and global headquarters in New York, is a research-based global pharmaceutical company. Pfizer discovers, develops, manufactures and markets leading prescription medicines for humans and animals, and many of the world's best-known consumer treatments. Every month, over two million patients in the UK are prescribed a Pfizer medicine. It is estimated that on any given day, 40 million people around the world are treated with a Pfizer medicine.

Roche and GlaxoSmithKline

    Roche  GlaxoSmithKline

Roche is one of the world's leading research-based healthcare groups. With the aim of enhancing people's health and quality of life, our core businesses in pharmaceuticals and diagnostics provide innovative products and services for the prevention, diagnosis and treatment of disease. In the UK, Roche employs around 1,800 people in prescription and over the counter medicines and diagnostics. Together, our businesses in the UK strive to make a real difference to healthcare, the UK's health services and, most importantly, people's lives.

GSK, one of the world's leading research-based pharmaceutical and healthcare companies, is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Servier Laboratories


Servier Laboratories is the UK subsidiary of The Servier Research Group, the leading independent French research based pharmaceutical company established in 1954.

The key franchises of the Servier Research Group are:

  • Cardiovascular disease
  • Diabetes
  • Rheumatology
  • Central Nervous System
  • Oncology

In 2005, Servier Laboratories had an annual UK turnover of close to £100 million and now ranks within the top 15 largest pharmaceutical companies in the UK.
Servier Laboratories was the fastest growing pharmaceutical company in the UK in 2005 with a growth rate of 29% against an industry average of around 6%.

Shire Pharmaceuticals Group plc

    Shire Pharmaceuticals Group plc

Shire Pharmaceuticals Group plc (Shire) is a global specialty pharmaceutical company with a strategic focus on meeting the needs of the specialist physician and currently focuses on developing projects and marketing products in the areas of central nervous system (CNS), gastrointestinal (GI), and renal diseases. Shire has operations in the world's key pharmaceutical markets (US, Canada, UK, France, Italy, Spain and Germany) as well as a specialist drug delivery unit in the US.

For further information on Shire, please visit the Company’s website:

The Alliance for Better Bone Health

    The Alliance for Better Bone Health

The Alliance for Better Bone Health was formed by Procter & Gamble and Aventis part of the sanofi-aventis Group, in May 1997 to promote bone health and disease awareness through numerous activities to support physicians and patients around the globe.

Procter & Gamble

    Proctor & Gamble

Three billion times a day, P&G brands touch the lives of people around the world. The company has one of the strongest portfolios of trusted, quality, leadership brands, including Actonel®, Asacol®, Vicks®, Pepto-bismol®, Metamucil®, Thermacare®, Crest®, Oral-B®, Pampers®, Ariel®, Always®, Pantene®, Herbal Essences®, Mach3®, Fairy®, Ace®, Lenor®, M. Propre®, Tampax®, Tempo®, Dash®, Pringles®, Iams®, Eukanuba®, Duracell®, Olay®, Head & Shoulders®, Wella, Gillette®, and Braun.

The P&G community consists of almost 140,000 employees working in over 80 countries worldwide. Please visit for the latest news and in-depth information about P&G and its brands. For more information about P&G Pharmaceuticals, please visit

sanofi aventis

    sanofi aventis; because health matters

Sanofi-aventis is the world’s third-largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. At sanofi-aventis we are committed to researching, developing and bringing to market new and innovative healthcare products so we can fulfil our mission… Because health matters.

Immunodiagnostic Systems


Immunodiagnostic Systems (IDS) offers a range of esoteric immunoassay kits for clinical and research use. The company focuses in Bone & Mineral Metabolism and Growth Factor research, and engages in collaborative projects with researchers worldwide.

IDS is a leader in the field of Vitamin D analysis, offering both manual and automated 25(OH) Vitamin D methods, an award-winning 1,25-Dihydroxy Vitamin D RIA system, and now announces OCTEIA 1,25(OH)2 Vitamin D, an EIA employing the proven immunocapsule sample preparation.

IDS offers a full range of Bone & Skeletal products, including BoneTRAP® (Tartrate-Resistant Acid Phosphatase 5b), MouseTRAP™, RatTRAP™, Bone-Specific Alkaline Phosphatase (Ostase® BAP), Intact PTH, urinary DPD, RANKL & OPG for both clinical and research (animal) use.

IDS OsteoSite™ antibodies include multiple forms of PTHrp, Cathepsin K, Osteoarthritis Matrix Antigen (a Collagen VI epitope) and a specific Osteoclast Antigen; the GroPep range has multi-species Growth Factor and GF-Binding Protein antibodies; and the Eurodiagnostica range has antibodies to many matrix antigens, neuropeptides and associated reagents.

Dentine discs are available for osteoclast activity studies in vitro, suitable for use in microtitre wells.


    Oxford Biosystems Ltd

MXD Ltd. are distributors for OsteoGram Osteoporosis software. A standard 8 by 10 inch hand X-Ray is used. Two posterior anterior of left hand fingers are acquired at two differing intensity, using a template with an aluminium wedge phantom. From this BMD is obtained. Reference is made to a US data base and T and Z scores are obtained.

MXD Ltd will also show the DicoMeasure orthopaedic measurement software for pre and post operative analysis and review of implants.

For information about either the Osteoporosis or Orthopaedic software, please come and talk to us at the MXD stand. We look forward to meeting you.

Olympus KeyMed

    Olympus KeyMed

A wholly-owned subsidiary of the Olympus Corporation of Japan, Olympus KeyMed is an important part of the global Olympus network, with specific responsibility for the development and manufacture of medical and industrial equipment for distribution worldwide. Olympus KeyMed’s medical business is made up of six distinct divisions, giving a complete focus to all aspects of the healthcare market. The Imaging Systems division is responsible for the Olympus range of arthroscopy products, and the popular TrueView range, including the innovative TrueView Direct Integrated Camera System, which will be on show at the Bone Research Society and British Orthopaedic Research Society First Joint Meeting.
For further information, visit the company’s website at


    Orthodynamics:  solutions in orthopaedics

Orthodynamics has expertise as a developer, manufacturer and supplier of specialist hip and knee implants for use in orthopaedics. The exciting product portfolio has an enviable reputation of being able to provide the orthopaedic surgeon with both off the shelf and custom made hip and knee implants for specific patients' needs. Established by Dr. John Bradley in 1986, and now part of the Summit Medical Group since 2003, the company has grown to command a high level of clinical respect and regard within the United Kingdom, and in key overseas markets.

For further information, visit our website,

Oxford Biosystems Ltd

    Oxford Biosystems Ltd

Oxford Biosystems is a supplier of in-vitro-diagnostics and immunochemicals for routine and research. We are specialized in new innovative immunoassays and other analytical methods e.g. HPLC, PCR, in different areas of medical laboratory diagnostics, medical research and industrial laboratories. All our products are sourced from innovative organizations that have a proven track record in developing and manufacturing diagnostic kits.

Oxford Biosystems has become a leading resource for clinical researchers looking for high-performance diagnostic kits in a number of areas:
Androgen Assessment, Anemia, Angiogenic Factors, Animal Testing, Anti-Ageing, Preventive Medicine, Autoimmune, Biogenic Amines, Bone & Mineral Metabolism, Cardiovascular, Renal Function, Cytokines, Diabetes Related, Eicosanoids, Energy Metabolism, Body Weight Reduction, Fertility, Reproduction, Gastroenterology, Nutrition, Growth Markers, Infection, Inflammation, Immunology, Mineral/Salt, Neural Tissue Damage, Oncology, Oxidative Stress, Thyroid Function, Research antibodies.


      PromoCell: biosciences alive

PromoCell provide a complete cell culture system with a multitude of human cells. In addition to the cells, each cell culture system contains the special growth medium optimized by PromoCell and which is ready to use. The media are either serum-free or contain as little serum as possible. The solutions necessary for the sub-cultivation of human cells are also supplied by PromoCell.

You will find Cytokines, ELISA Kits and Antibodies as well as further interesting products for the cell biology field (e.g. Reagents and Kits for cell transfection and cell analysis) in our PromoKine catalogue which will be published soon.

Regenerative Medicine   

    Regenerative Medicine

Regenerative Medicine provides a novel forum to address the important challenges and advances in the exploding field of stem cell research and regenerative medicine. Senior Editor, Stephen Minger (Kings College London, UK) and a panel of more than 60 international experts ensure that Regenerative Medicine delivers high quality, topical reviews, primary research, editorials and technology evaluations, all subject to rigorous peer review.



Stryker Corporation is a leader in the worldwide orthopaedic market and is one of the world’s largest medical device companies. Stryker delivers results through a wide range of capabilities including joint replacements, trauma, spine and micro implant systems, orthobiologics, powered surgical instruments, surgical navigation systems, endoscopic products as well as patient handling and emergency medical equipment.

We've invested over 20 years of research in developing orthobiologic technologies. These regenerative products can help patients who previously had few, if any, treatment options. This research also holds the promise of creating other kinds of orthobiologic regeneration -- with the potential to provide better results for countless people.



Technoclone Ltd is a specialist in the field of bone, cartilage and mineral metabolism immunoassays and is the exclusive distributor in the UK and Ireland of both the Metra® range of Bone Marker assay kits from Quidel and the Bone and Cartilage assay kits from Nordic Bioscience Diagnostics.

The Nordic Bioscience range includes clinical tests for serum and urine CTX-I (CrossLaps®),N-MID Osteocalcin and urine CTX-II (CartiLaps®), as well as the preclinical RatLaps and CrossLaps for Culture CTX-I kits, Rat-MID Osteocalcin and serum and urine pre-clinical CartiLaps® (CTX-II) kits. Nordic Bioscience also supply bovine bone slices available in a range of sizes for different assay plates.

The Metra® range of ELISA assays includes a highly specific Bone Alkaline Phosphatase (BAP) assay, serum Osteocalcin, Collagen Type –1 C-Terminal propeptide (CICP), DPD and Total DPD, PYD, alpha-1 Helical Peptide and YKL-40, as well as a chromogenic Creatinine assay and other research reagents.
Details of new kits from both Nordic Bioscience and Quidel will be available at the BRS meeting, including

  • Metra® TRAcP 5b ELISA
  • Alpha CrossLaps (CTX-I) for bone metastases
  • Calcitonin ELISA
  • Intact PTH ELISA
  • Metra® Osteoprotegerin

Technoclone also markets the IBEX range of Cartilage diagnostics and an extensive range of autoimmune assays, complement diagnostics and multiplex cytokine assays.


    Zimmer Ltd: Confidence in your hands

Zimmer Ltd is the world’s #1 pure play orthopaedic company, so when it comes to keeping up with what’s new in orthopaedics a visit to our stand is essential.
Zimmer is leading the way in Minimally Invasive Surgery (MIS™), new applications such as Trabecular Metal™ Technology providing innovative solutions for cementless fixation, and Durom™ Hip Resurfacing drawing upon the experience of over 250,000 metal-on-metal (Metasul) implantations.
Our specialist staff will be available throughout the exhibition and will be delighted to update you on all Zimmer’s latest products and technologies.


Page Footer. Contact